Search results for " Ly"

showing 10 items of 2487 documents

Immune Thrombocytopenia in Antiphospholipid Syndrome: Is It Primary or Secondary?

2021

Antiphospholipid syndrome (APS) is frequently associated with thrombocytopenia, in most cases mild and in the absence of major bleedings. In some patients with a confirmed APS diagnosis, secondary immune thrombocytopenia (ITP) may lead to severe thrombocytopenia with consequent major bleeding. At the same time, the presence of antiphospholipid antibodies (aPL) in patients with a diagnosis of primary ITP has been reported in several studies, although with some specific characteristics especially related to the variety of antigenic targets. Even though it does not enter the APS defining criteria, thrombocytopenia should be regarded as a warning sign of a “high risk” APS and thus thoroughly ev…

Pediatricsmedicine.medical_specialtyQH301-705.5medicine.drug_classMedicine (miscellaneous)thrombocytopeniaReviewGeneral Biochemistry Genetics and Molecular BiologyAntigenimmune system diseasesAntiphospholipid syndromehemic and lymphatic diseasesmedicineBiology (General)Antiphospholipid antibodies Antiphospholipid syndrome Immune thrombocytopenia Lupus anticoagulant ThrombocytopeniaLupus anticoagulantbiologybusiness.industryAnticoagulantantiphospholipid antibodiesmedicine.diseaseThrombosisImmune thrombocytopeniaVenous thrombosislupus anticoagulantimmune thrombocytopeniabiology.proteinAntibodybusinessAntiphospholipid antibodieantiphospholipid syndromeBiomedicines
researchProduct

Splenomegaly Impacts Prognosis in Essential Thrombocythemia and Polycythemia Vera: A Single Center Study

2019

Splenomegaly is one of the major clinical manifestations of primary myelofibrosis and is common also in other chronic Philadelphia-negative myeloproliferative neoplasms, causing symptoms and signs and affecting quality of life of patients diagnosed with these diseases. We aimed to study the impact that such alteration has on thrombotic risk and on the survival of patients with essential thrombocythemia and patients with Polycythemia Vera (PV). We studied the relationship between splenomegaly (and its grade), thrombosis and survival in 238 patients with et and 165 patients with PV followed at our center between January 1997 and May 2019.

Pediatricsmedicine.medical_specialtySingle CenterArticle03 medical and health sciences0302 clinical medicinePolycythemia veraQuality of lifehemic and lymphatic diseasesmedicineMyelofibrosisPolycythemia VeraThrombotic riskessential thrombocythemiaEssential thrombocythemiabusiness.industrylcsh:RC633-647.5Hematologylcsh:Diseases of the blood and blood-forming organsmedicine.diseaseThrombosis030220 oncology & carcinogenesisSplenomegalysplenomegaly; polycythemia vera; essential thrombocythemiabusiness030215 immunologyHematology Reports; Volume 11; Issue 4; Pages: 8281
researchProduct

Factors Associated with Nonsuppression of HIV Infection in the Spanish VACH Cohort.

2020

We aim to determine the prevalence of HIV nonsuppression and factors associated with it. This is a cross-sectional multicenter study carried out in January 2016 with data of the VACH Cohort, a registry participated by 23 hospitals from most regions of Spain. The prevalence of HIV nonsuppression, defined as HIV RNA ≥200 copies/mL, is documented. The possible association of HIV nonsuppression with sociodemographic and clinical variables is assessed with a logistic regression analysis. A total of 30,843 adult patients are included; 7,358 of them (23.86%) have nonsuppressed HIV. An association is found between nonsuppression of HIV and the following variables: lower body mass index, lower age o…

Pediatricsmedicine.medical_specialtybusiness.industryCoinfectionImmunologyHuman immunodeficiency virus (HIV)HIV InfectionsViral Loadmedicine.disease_causeCD4 Lymphocyte CountInfectious DiseasesCross-Sectional StudiesMulticenter studyAnti-Retroviral AgentsRisk FactorsVirologyChild PreschoolCohortMedicineHumansbusinessAIDS research and human retroviruses
researchProduct

Depression and cognitive deficits as long-term consequences of thrombotic thrombocytopenic purpura

2017

BACKGROUND Thrombotic thrombocytopenic purpura (TTP) is an acute life-threatening microangiopathy with a tendency of relapse characterized by consumptive thrombocytopenia, microangiopathic hemolytic anemia, and spontaneous von Willebrand factor–induced platelet clumping leading to microthrombi. The brain is frequently affected by microthrombi leading to neurologic abnormalities of varying severity. STUDY DESIGN AND METHODS The aim of this observational cohort study was to investigate the prevalence of depression and cognitive deficits in 104 patients having survived acute TTP. TTP survivors were repeatedly assessed by means of different standardized questionnaires to evaluate depression (ID…

Pediatricsmedicine.medical_specialtybusiness.industryImmunologyMicroangiopathyThrombotic thrombocytopenic purpuraCognitionHematologyMicroangiopathic hemolytic anemia030204 cardiovascular system & hematologymedicine.disease03 medical and health sciences0302 clinical medicinehemic and lymphatic diseasesImmunology and AllergyMedicineEffects of sleep deprivation on cognitive performanceYoung adultbusinessDepression (differential diagnoses)030215 immunologyCohort studyTransfusion
researchProduct

Synthesis and photocytotoxic activity of [1,2,3]triazolo[4,5-h][1,6]naphthyridines and [1,3]oxazolo[5,4-h][1,6]naphthyridines

2018

Abstract [1,2,3]Triazolo[4,5-h][1,6]naphthyridines and [1,3]oxazolo[5,4-h][1,6]naphthyridines were synthesized with the aim to investigate their photocytotoxic activity. Upon irradiation, oxazolo-naphtapyridines induced light-dependent cell death at nanomolar/low micromolar concentrations (EC50 0.01–6.59 μM). The most photocytotoxic derivative showed very high selectivity and photocytotoxicity indexes (SI = 72–86, PTI>5000), along with a triplet excited state with exceptionally long lifetime (18.0 μs) and high molar absorptivity (29781 ± 180 M−1cm−1 at λmax 315 nm). The light-induced production of ROS promptly induced an unquenchable apoptotic process selectively in tumor cells, with mitoch…

Pharmaceutical ScienceApoptosisMitochondrionPhotochemiotherapy; Photosensitizing agents; Reactive oxygen species; [123]Triazolo[45-h][16]naphthyridines; [13]oxazolo[54-h][16]naphthyridines; Pharmacology; Drug Discovery; Pharmaceutical Science; Organic Chemistry01 natural sciencesMedicinal chemistry[13]oxazolo[54-h][16]naphthyridinechemistry.chemical_compoundDrug Discovery6]naphthyridineschemistry.chemical_classification0303 health sciencesTumorPhotosensitizing AgentsCell DeathSinglet OxygenSinglet oxygenPhotochemiotherapy; Photosensitizing agents; Reactive oxygen species; [1; 2; 3]Triazolo[4; 5-h][1; 6]naphthyridines; [1; 3]oxazolo[5; 4-h][1; 6]naphthyridines; Apoptosis; Cell Death; Cell Line; Tumor; Humans; Lysosomes; Mitochondria; Naphthyridines; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species; Singlet OxygenGeneral MedicineLysosomeMitochondriaExcited stateReactive oxygen specie5-h][1HumanProgrammed cell death2NaphthyridinePhotochemiotherapy3]Triazolo[4Cell Line03 medical and health sciences4-h][1Cell Line TumorHumansNaphthyridines030304 developmental biologyPharmacologyReactive oxygen speciesPhotosensitizing agent010405 organic chemistryOrganic ChemistryApoptosi0104 chemical sciences3]oxazolo[5chemistryPhotochemotherapyCell cultureApoptosis[123]Triazolo[45-h][16]naphthyridine[1LysosomesReactive Oxygen SpeciesDerivative (chemistry)
researchProduct

Comparative Chemical Compositions of Fresh and Stored Vesuvian PDO "Pomodorino Del Piennolo" Tomato and the Ciliegino Variety

2018

The Vesuvian Piennolo cherry tomato (Lycopersicon esculentum Miller) (PdP) is an old and typical variety grown in the Campania region (Italy). PdP is referred to as a long-storage tomato due to its thick and coriaceous skin that allows long post-harvest storage and it has been granted Protected Designation of Origin (PDO) status since 2009. In this study, the chemical composition, focusing in particular on organic acids, antioxidant molecules and volatile compounds, were investigated in PdP and compared to another typical variety in Campania, the Ciliegino tomato (CIL). Chemical characterization was evaluated for both the CIL and PdP varieties during storage in the same environmental condit…

Pharmaceutical Scienceantioxidants fractionsLycopersiconAntioxidantsArticleAnalytical ChemistryNOlcsh:QD241-441storagechemistry.chemical_compound0404 agricultural biotechnologyPomodorino del Piennolo del Vesuvio; antioxidants fractions; chemical composition; cherry tomato; organic acids; storage; volatile organic compoundsCherry tomatolcsh:Organic chemistrySolanum lycopersicumvolatile organic compoundsDrug Discoveryorganic acidschemical compositionPhysical and Theoretical ChemistryChemical compositionPomodorino del Piennolo del VesuviobiologyChemistryOrganic Chemistryfood and beverages04 agricultural and veterinary sciencesbiology.organism_classification040401 food scienceLycopeneHorticultureChemistry (miscellaneous)Geographic originFruitMolecular Medicinecherry tomato
researchProduct

Identification of pyrrolo[3',4':3,4]cyclohepta[1,2-d][1,2]oxazoles as promising new candidates for the treatment of lymphomas

2023

Unsatisfactory outcomes for relapsed/refractory lymphoma patients prompt continuing efforts to develop new therapeutic strategies. Our previous studies on pyrrole-based anti-lymphoma agents led us to synthesize a new series of twenty-six pyrrolo[3′,4':3,4]cyclohepta[1,2-d] [1,2]oxazole derivatives and study their antiproliferative effects against a panel of four non-Hodgkin lymphoma cell lines. Several candidates showed significant anti-proliferative effects, with IC50's reaching the sub-micromolar range in at least one cell line, with compound 3z demonstrating sub-micromolar growth inhibitory effects towards the entire panel. The VL51 cell line was the most sensitive, with an IC50 value of…

Pharmacology2-d][1Antitumor agentsLymphoma4’:3Organic ChemistryGeneral MedicineIsoxazolespyrrolo[3′2]oxazolesHematological malignanciesAntitumor agents; Hematological malignancies; Isoxazoles; Lymphoma; pyrrolo[3′4’:34]cyclohepta[12-d][12]oxazolespyrrolo[3′4’:34]cyclohepta[12-d][12]oxazoles4]cyclohepta[1Drug Discovery
researchProduct

Monocyte to lymphocyte blood ratio in tuberculosis and HIV patients: Comparative analysis, preliminary data

2017

Recent data confirmed the hypothesis suggested by historical studies that the ratio of peripheral blood monocytes to lymphocytes (M/L) is associated with the risk of tuberculosis (TB) disease. We retrospectively analyzed the electronic health records of tuberculosis and HIV-positive patients who had followed day-care programs at the AIDS Center of the University of Palermo, Italy. 261 patients were recruited and divided into 6 groups as follows: healthy control group (HCG: 47 pts), latent HIV negative infected TB group (LIG, 43 pts), active HIV negative tuberculosis (TAG: 61 pts), treated tuberculosis HIV negative (TTG: 44 pts), HIV drug-naive patients tested TST and QFT-IT-negative with ne…

PharmacologyCo-infected HIV/TBCTuberculosiDrug Discovery3003 Pharmaceutical ScienceCo-infected HIV/TBC; HIV infection; Monocyte to lymphocyte blood RATIO; Tuberculosis; Pharmacology; Drug Discovery3003 Pharmaceutical ScienceMonocyte to lymphocyte blood RATIOHIV infection
researchProduct

Flavonoids ofRhamnus lycioides; Part 2

1988

PharmacologyFolk medicineTraditional medicinebiologyChemistryOrganic ChemistryRhamnus lycioidesPharmaceutical ScienceEriodictyolbiology.organism_classificationAnalytical Chemistrychemistry.chemical_compoundComplementary and alternative medicineDrug DiscoveryMolecular MedicinePlanta Medica
researchProduct

Comparison of clot lysis activity and biochemical properties of originator tenecteplase (Metalyse®) with those of an alleged biosimilar

2014

The bioengineered tissue plasminogen activator tenecteplase is an important treatment modality of acute myocardial infarction recommended by international guidelines. Following introduction of originator tenecteplase (brand names Metalyse(®) and TNKase(®)), a "biosimilar" tenecteplase became available for commercial use in India under the brand name Elaxim(®) in the absence of Indian biosimilar guidelines which came into force from September 15th, 2012. Based on a report of biochemical and fibrinolytical differences between Metalyse and Elaxim, we have systematically compared them in a range of routine quality testing assays. As compared to Metalyse, Elaxim exhibited less clot lysis activit…

PharmacologyGlycosylationtenecteplaseglycosylationbusiness.industryChinese hamster ovary cellTenecteplaseBiosimilarPharmacologyTissue plasminogen activatorSialic acidchemistry.chemical_compoundClot lysischemistryimpuritymedicinePharmacology (medical)Clinical efficacyOriginal Research Articlebiosimilarclot lysisbusinessmedicine.drugFrontiers in Pharmacology
researchProduct